Clover Health Investments Crop. ($CLOV) Stock Forecast: Up 5.8% Today

What is Clover Health Investments Crop.?

Clover Health Investments Corp (CLOV) is a healthcare technology company that offers software to improve medical outcomes. The stock had a bullish movement today.

Why is Clover Health Investments Crop. going up?

CLOV stock is up 5.8% on May 7, 2026 14:51

• The bullish movement in CLOV could be attributed to investors gaining confidence in the company's ability to navigate through the ongoing securities class action lawsuit.
• Despite the legal challenges, the market seems to be optimistic about Clover Health's future prospects and potential for growth in the healthcare technology sector.
• Investors might be reassured by the company's response to the allegations and its efforts to address any concerns raised by the Department of Justice investigation and related-party deals.
• The upcoming deadline for the lead plaintiff in the securities class action lawsuit could also be driving increased interest and trading activity in CLOV as investors position themselves based on potential outcomes.

CLOV Price Chart

CLOV Technical Analysis

CLOV News

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III Investors to Secure Counsel Before Important Deadline - CLOV, CLOVW, IPOC

The Rosen Law Firm is reminding investors of Clover Health Investments, Corp. (CLOV, CLOVW, IPOC) that the lead plaintiff deadline in a securities class action lawsuit is April 6, 2021. The lawsuit alleges that Clover Health made false and misleading statements regarding its business, operations, and prospects, specifically concerning a Department of Justice investigation, undisclosed related-party deals, and misleading marketing practices. Investors who purchased Clover securities during the Class Period (October 6, 2020, and February 4, 2021) or pursuant to the December 2020 merger are encouraged to contact the firm for compensation information.

https://www.newsfilecorp.com/release/76477/ROSEN-TRUSTED-INVESTOR-COUNSEL-Encourages-Clover-Health-Investments-Corp.-fka-Social-Capital-Hedosophia-Holdings-Corp.-III-Investors-to-Secure-Counsel-Before-Important-Deadline-CLOV-CLOVW-IPOC?lang=fr

Trending Today

Shoals Technologies Group Inc. ($SHLS) Stock Forecast: Up 10.0% Today

Celanese Corporation ($CE) Stock Forecast: Down 5.0% Today

SolarEdge Technologies, Inc. ($SEDG) Stock Forecast: Up 6.8% Today

Workday Inc. ($WDAY) Stock Forecast: Down 5.0% Today

Applied Materials Inc. ($AMAT) Stock Forecast: Up 6.4% Today

Tesla Inc. ($TSLA) Stock Forecast: Up 5.7% Today

Teradyne, Inc. ($TER) Stock Forecast: Up 5.2% Today

GlobalFoundries Inc. ($GFS) Stock Forecast: Up 5.6% Today

Intel Corporation ($INTC) Stock Forecast: Up 13.2% Today

Block Inc. ($XYZ) Stock Forecast: Up 8.2% Today

Clover Health Investments Crop. Price History

22.03.2026 - CLOV Stock was up 5.2%

• The positive sentiment surrounding CLOV stock today may be linked to executives having shares withheld for tax obligations related to the vesting of restricted stock units (RSUs), signaling confidence in the company's future growth.
• Tax-related share withholding actions by top executives, including the CEO, CFO, and Chief Legal Officer, may have bolstered investor trust in the leadership team's dedication to long-term success, boosting investor confidence and elevating the stock price.
• These transactions reflect transparency and adherence to tax regulations, potentially boosting the company's reputation and credibility with investors and stakeholders, fueling the bullish market movement in CLOV stock today.

02.03.2026 - CLOV Stock was up 6.0%

• The rise in CLOV stock today could be linked to the announcement of an upcoming CFO transition. Despite this change, the company reiterated its financial outlook for 2026, which likely boosted investor confidence in its strategy and financial health.
• Although Vanguard reported holding zero shares in Clover Health, causing initial concerns, the market sentiment appeared to shift positively due to the company's reaffirmed financial guidance and growth prospects.
• An AI Analyst rated CLOV stock as Neutral citing a mix of financial quality and technical pressures, which may have dampened some market enthusiasm. However, the focus on membership growth and profitability goals likely balanced this, contributing to the observed bullish trend.

21.03.2026 - CLOV Stock was up 10.2%

• The bullish movement in CLOV's stock today is possibly influenced by executives' decision to withhold shares for tax obligations relating to the vesting of restricted stock units (RSUs), showcasing confidence in the company's future performance.
• Routine tax-related dispositions by key executives, including the CEO, CFO, and Chief Legal Officer, reflect their dedication to Clover Health's long-term success, likely bolstering investor confidence.
• These transactions could be seen as a positive display of transparency and sound financial management, potentially contributing to the upward momentum in CLOV's stock price.
• Overall, the market's favorable reaction to the executives' actions hints at their trust in Clover Health's growth potential and financial stability.

18.02.2026 - CLOV Stock was down 5.1%

• Executives at Clover Health, including Jamie L. Reynoso and Conrad Wai, had shares withheld to cover tax obligations related to vested restricted stock units (RSUs).
• The automatic withholding of shares for tax purposes may have led to increased selling pressure on the stock, contributing to the bearish movement.
• Investors might interpret the executives' actions as a lack of confidence in the company's future performance, further dampening market sentiment towards Clover Health.
• The series of tax-related share withholdings could have signaled potential concerns about the company's financial health or regulatory challenges, prompting investors to react bearishly.

22.00.2026 - CLOV Stock was up 5.3%

• The rise in CLOV stock could be linked to the CEO's recent share sales, potentially indicating confidence in the company's future.
• Upbeat forecasts for profitability in 2026 and an annual increase in Medicare Advantage membership likely boosted investor confidence and led to the stock's upward movement.
• Despite a lack of profitability over the past year, the expectation of turning profitable this year and being deemed slightly undervalued by InvestingPro could have additionally stimulated investor interest in CLOV.

04.02.2026 - CLOV Stock was up 6.8%

• The company recorded remarkable 40% revenue growth in 2025, hitting $1.9 billion, and saw a 38% increase in its Medicare Advantage membership to 113,803. This strong financial performance likely influenced the stock's positive movement.
• Despite reporting a GAAP net loss in 2025, Clover Health achieved non-GAAP profitability, indicating effective operational practices and cost control measures.
• Clover Health's forecast of achieving GAAP net income profitability in 2026, coupled with revenue guidance ranging between $2.81 billion and $2.92 billion, presented a promising future for investors, driving bullish sentiment in the market.
• The company's strategic efforts, including enhancements to its Clover Assistant platform, expansion into new regions, and introduction of new products, showcase its dedication to growth and innovation, further enhancing investor trust in the stock.

05.02.2026 - CLOV Stock was down 6.7%

• Today's downturn in Clover Health's stock (CLOV) can be linked to various factors:
• Strong revenue growth and an increase in Medicare Advantage membership were overshadowed by higher net losses and loss per share in the recent SEC 10-K filing, causing concerns among investors about the company's profitability.
• The company's aim to reach GAAP profitability by 2026, while making progress in non-GAAP profitability, has raised doubts about its financial targets.
• Efforts to expand product offerings and geographic reach, as outlined in the Form 10-K, may result in higher operating expenses and competitive challenges, prompting investor wariness.
• General market volatility in the healthcare sector or broader market conditions could have influenced market sentiment, leading some investors to approach Clover Health's stock with more caution.

06.03.2026 - CLOV Stock was up 5.3%

• The bullish movement in CLOV stock could be attributed to the positive sentiment generated by executives receiving significant RSU grants, indicating confidence in the company's future performance and growth prospects.
• The announcement of the CFO transition and the reaffirmation of the 2026 financial outlook might have also contributed to investor optimism, showcasing stability and strategic planning within the company.
• The consistent vesting schedule of RSUs for key executives like Brady Patrick Priest, Karen Soares, Jamie L. Reynoso, and Wai Conrad, highlights a long-term commitment to the company's success, instilling trust among shareholders and potential investors.
• Overall, these developments suggest a positive outlook for Clover Health, reinforcing investor confidence and driving the bullish movement in CLOV stock.

03.01.2026 - CLOV Stock was down 5.6%

• The bearish movement in CLOV stock today may be linked to the upcoming release of its fourth quarter and full year 2025 financial results. Investors seem cautious about the company's performance, resulting in a sell-off of shares ahead of the announcement. Market sentiment appears to be affected by concerns about Clover Health Investments, Corp.'s financial health and growth prospects.

07.04.2026 - CLOV Stock was up 5.8%

• The bullish movement in CLOV could be attributed to investors gaining confidence in the company's ability to navigate through the ongoing securities class action lawsuit.
• Despite the legal challenges, the market seems to be optimistic about Clover Health's future prospects and potential for growth in the healthcare technology sector.
• Investors might be reassured by the company's response to the allegations and its efforts to address any concerns raised by the Department of Justice investigation and related-party deals.
• The upcoming deadline for the lead plaintiff in the securities class action lawsuit could also be driving increased interest and trading activity in CLOV as investors position themselves based on potential outcomes.

24.02.2026 - CLOV Stock was down 6.5%

• Today's bearish movement in Clover Health's stock (CLOV) could be linked to a series of insider selling activities by top executives, such as CEO Jamie L. Reynoso and General Counsel Karen Soares. This may be perceived by the market as a lack of confidence in the company's future performance, resulting in a negative investor sentiment.
• Executives' automatic withholding of shares to cover tax obligations from RSU vesting might suggest potential cash flow issues or personal financial commitments, which could further affect investor confidence in the stock.
• In summary, insider selling paired with tax-related share withholding likely contributed to the stock's bearish performance today, as investors react to signs of potential internal issues within the company.

13.03.2026 - CLOV Stock was up 5.3%

• The bullish movement in CLOV's stock could be attributed to the positive sentiment generated by recent filings of beneficial ownership by key executives, including the VP of Finance, interim CFO, and CEO of Medicare Advantage.
• Disclosure of significant share ownership and RSUs by these executives indicates their confidence in the company's future performance, likely appealing to investors.
• The CEO of Medicare Advantage using vested shares to cover tax obligations demonstrates commitment to long-term growth, which could enhance investor trust and optimism in CLOV's prospects.
• The various ownership disclosures and transactions by key executives at Clover Health Investments probably played a role in today's bullish movement in CLOV's stock.